Stocks
Cardiovascular Systems Financial Statements () |
||||||||||
| Cardiovascular Systemssmart-lab.ru | % | 2022Q4 | 2022Q4 | 2023Q1 | 2023Q1 | 2023Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.06.2022 | 18.08.2022 | 30.09.2022 | 03.11.2022 | 09.02.2023 | 09.02.2023 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.062 | 62.5 | 0.060 | 59.7 | 61.5 | 183.7 | |||
| Operating Income, bln rub | -0.009 | -9.49 | -0.011 | -10.9 | -8.53 | -28.9 | ||||
| EBITDA, bln rub | ? | -0.008 | -9.14 | -0.009 | -9.02 | -8.18 | -26.4 | |||
| Net profit, bln rub | ? | -0.010 | -9.69 | -0.011 | -10.6 | -7.89 | -28.2 | |||
| OCF, bln rub | ? | 0.000 | -9.83 | 0.000 | -13.7 | -3.55 | -27.0 | |||
| CAPEX, bln rub | ? | 0.000 | 1.000 | 0.000 | 0.688 | 2.04 | 3.73 | |||
| FCF, bln rub | ? | 0.000 | -10.8 | 0.000 | -14.3 | -5.59 | -30.8 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| OPEX, bln rub | 0.055 | 55.7 | 0.054 | 53.9 | 51.5 | 161.2 | ||||
| Cost of production, bln rub | 0.016 | 16.3 | 0.017 | 16.7 | 18.5 | 51.4 | ||||
| R&D, bln rub | 0.009 | 8.77 | 0.009 | 9.06 | 9.53 | 27.4 | ||||
| Interest expenses, bln rub | 0.000 | 0.407 | 0.000 | 0.406 | 0.404 | 1.22 | ||||
| Assets, bln rub | 0.323 | 322.7 | 0.312 | 312.0 | 311.5 | 311.5 | ||||
| Net Assets, bln rub | ? | 0.249 | 249.5 | 0.242 | 242.2 | 239.4 | 239.4 | |||
| Debt, bln rub | 0.000 | 20.3 | 0.000 | 21.4 | 20.1 | 20.1 | ||||
| Cash, bln rub | 0.160 | 159.8 | 0.144 | 143.7 | 132.0 | 132.0 | ||||
| Net debt, bln rub | -0.16 | -139.5 | -0.14 | -122.3 | -111.9 | -111.9 | ||||
| Ordinary share price, rub | 14.4 | 14.4 | 13.9 | 13.9 | 13.6 | 13.6 | ||||
| Number of ordinary shares, mln | 39.3 | 39.3 | 39.6 | 39.6 | 39.7 | 39.7 | ||||
| Market cap, bln rub | 565 | 565 | 549 | 549 | 540 | 540 | ||||
| EV, bln rub | ? | 565 | 425 | 549 | 427 | 428 | 428 | |||
| Book value, bln rub | 0 | 234 | 0 | 227 | 224 | 224 | ||||
| EPS, rub | ? | 0.00 | -0.25 | 0.00 | -0.27 | -0.20 | -0.71 | |||
| FCF/share, rub | 0.00 | -0.28 | 0.00 | -0.36 | -0.14 | -0.78 | ||||
| BV/share, rub | 0.01 | 5.94 | 0.01 | 5.73 | 5.66 | 5.66 | ||||
| EBITDA margin, % | ? | -13.5% | -14.6% | -15.7% | -15.1% | -13.3% | -14.3% | |||
| Net margin, % | ? | -15.5% | -15.5% | -17.8% | -17.8% | -12.8% | -15.4% | |||
| FCF yield, % | ? | -1.01% | -3.44% | -2.50% | -5.12% | -6.23% | -5.69% | |||
| ROE, % | ? | -14 935% | -18.8% | -11 983% | -16.4% | -19.9% | -11.8% | |||
| ROA, % | ? | -11 547% | -14.5% | -9 299% | -12.7% | -15.3% | -9.06% | |||
| P/E | ? | -15.2 | -12.0 | -18.9 | -13.8 | -11.4 | -19.1 | |||
| P/FCF | -29.0 | -19.5 | -16.0 | -17.6 | ||||||
| P/S | ? | 2.45 | 1.93 | 3.14 | 2.34 | 1.82 | 2.94 | |||
| P/BV | ? | 2 417 | 2.42 | 2 421 | 2.42 | 2.41 | 2.41 | |||
| EV/EBITDA | ? | -16.8 | -10.0 | -21.5 | -11.5 | -9.47 | -16.3 | |||
| Debt/EBITDA | 0.00 | 3.29 | 0.01 | 3.30 | 2.47 | 4.25 | ||||
| R&D/CAPEX, % | 877.3% | 1 316% | 467.5% | 734.4% | ||||||
| CAPEX/Revenue, % | 0.00% | 1.60% | 0.00% | 1.15% | 3.32% | 2.03% | ||||
| Cardiovascular Systems shareholders | ||||||||||
